NCT04560894 2024-02-01
HCC
Sinocelltech Ltd.
Phase 2/3 Unknown
Clinical Trials
27 trialsNCT05062837 2024-01-23
Hepatectomy Combined With Camrelizumab and Apatinib in CNLC Stage IIIb HCC
Guangxi Medical University
Phase 2/3 Unknown
NCT05250843 2023-10-13
TACE/HAIC Combined With Lenvatinib and Sintilimab in Neoadjuvant Therapy for Intermediate-stage HCC
Third Affiliated Hospital, Sun Yat-Sen University
Phase 2/3 Unknown
NCT04797884 2023-06-28
ARTEMIS
THERABIONIC INC.
Phase 2/3 Unknown
NCT03859128 2023-03-31
JUPITER 04
Shanghai Junshi Bioscience Co., Ltd.
Phase 2/3 Unknown
NCT05280444 2022-12-29
Lipiodol-TACE With Idarubicin for Hepatocellular Carcinoma
Zhongda Hospital
Phase 2/3 Unknown
NCT05344924 2022-12-29
TACE Combined With Penpulimab and Anlotinib for Advanced HCC
Zhongda Hospital
Phase 2/3 Unknown
NCT05544253 2022-09-16
Safety and Efficacy of Mitomycin C-based HIPEC After srHCC and PM of HCC
West China Hospital
Phase 2/3 Unknown
NCT02794337 2022-04-27
TACE-SBRT
Tata Memorial Hospital
Phase 2/3 Unknown
NCT04909866 2021-06-02
The Efficacy and Safety of TACE, Lenvatinib and Camrelizumab in the Treatment of BCLC Stage B/C Hepatocellular Carcinoma: a Single-arm, Single-center, Open-label Study
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2/3 Unknown
NCT04167293 2021-03-23
ISBRT01
Sun Yat-sen University
Phase 2/3 Unknown
NCT03794440 2021-01-22
A Study to Evaluate the Efficacy and Safety of Sintilimab in Combination With IBI305 (Anti-VEGF Monoclonal Antibody) Compared to Sorafenib as the First-Line Treatment for Advanced Hepatocellular Carcinoma.
Innovent Biologics (Suzhou) Co. Ltd.
Phase 2/3 Unknown
NCT03642561 2020-07-28
Evaluation the Treatment Outcome for RFA in Patients With BCLC Stage B HCC in Comparison With TACE
Fudan University
Phase 2/3 Unknown
NCT03592706 2020-04-16
Autologous Immune Killer Cells to Treat Liver Cancer Patients as an Adjunct Therapy
Ivy Life Sciences, Co., Ltd
Phase 2/3 Unknown
NCT04319484 2020-03-24
LLTHVV
RenJi Hospital
Phase 2/3 Unknown
NCT04168944 2019-11-19
Lenvatinib Following Liver Transplantation in Patients With High-Risk Hepatocellular Carcinoma
RenJi Hospital
Phase 2/3 Unknown
NCT04025437 2019-09-04
Neoadjuvant Radiotherapy for HCC Involving Type I PVTT
Guangxi Medical University
Phase 2/3 Unknown
NCT02767375 2017-08-10
HAICAT
Peking University Cancer Hospital & Institute
Phase 2/3 Unknown
NCT02702323 2016-03-08
Treatment Patients With Pulmonary Metastasis of Liver Cancer With Apatinib Combination With TACE: a Clinical Study
Zhejiang Cancer Hospital
Phase 2/3 Unknown
NCT02240771 2014-09-16
Transarterial Chemotherapy Compared With Oral Chemotherapy in the Treatment of Advanced Hepatocellular Carcinoma
All India Institute of Medical Sciences
Phase 2/3 Unknown
NCT01861912 2013-06-05
ACTION
Guangdong Provincial People's Hospital
Phase 2/3 Unknown
NCT01747642 2012-12-12
Safety and Efficacy of Oncoxin Plus Surafineb in Hepatocellular Carcinoma
Clinical Research Organization, Dhaka, Bangladesh
Phase 2/3 Unknown
NCT00843934 2012-10-19
ACE500
Nihon University
Phase 2/3 Unknown
NCT00522405 2012-07-16
Randomized Control Trial (RCT) of Transarterial Chemoembolization (TACE) Versus TACE and Oral Drug Therapy in the Treatment of Unresectable Hepatocellular Carcinoma
All India Institute of Medical Sciences
Phase 2/3 Unknown
NCT01438450 2012-07-13
OTCHCC
All India Institute of Medical Sciences
Phase 2/3 Unknown
NCT00561522 2010-07-21
Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection
Fudan University
Phase 2/3 Unknown
NCT00728078 2009-02-09
LDT-RFA
Sun Yat-sen University
Phase 2/3 Unknown